Screening in Pregnancy

     

The National Institute for Clinical Excellence (NICE) currently do not recommend routine antenatal screening for CMV. This because there is currently no way of preventing transmission of the virus to an unborn baby and no way to determine whether a baby will be born with problems.

A study in the US is testing whether CMV Immunoglobulin therapy may reduce the risk of transmission when given to pregnant women experiencing a primary CMV infection. This follows mixed results from previous studies of immunoglobulin therapy in Italy.  The US study is due to report in 2019.

In the meantime, CMV Action is working with researchers to try and secure funding for a pilot to test out how CMV screening in pregnancy could work within the NHS.

We will continue to campaign for change.

 

     

Our Stories

June 2014 I found out I had CMV in pregnancy and thought I would share my experience in the hope that it might help (sorry if this is a bit lengthy!) All had been well at my 12 week... Read more
April 1982 I guess I had a pretty typical childhood with some exceptions.  Here is what my mother has to say: “Kristen was born 10:58am on April 5th, 1982 weighing 6lbs 1oz after... Read more

Latest Events

Registered charity no: 1171773